Partnership Unveiled: Redox and Kno2 to Revolutionize Data Flow

Unveiling a New Era in Healthcare Data Exchange
Redox, recognized as a leader in healthcare interoperability, and Kno2, a pioneering force in healthcare communication, have forged a strategic alliance to tackle one of the industry’s longstanding challenges: the efficient exchange of clinical data across diverse healthcare networks and systems. By merging their strengths, they aim to make clinical data not only more accessible but also instantly usable for healthcare providers and organizations throughout the nation.
This powerful collaboration connects two industry giants. Together, Redox and Kno2 handle an impressive 40 billion transactions annually, reaching close to 160,000 healthcare providers. This extensive network represents a significant portion of health systems nationwide, including 75% of health systems and 80% of providers in non-acute sectors like therapy and post-acute care. The result is a comprehensive healthcare network that facilitates seamless clinical data exchange.
Addressing Interoperability Head-On
The alliance tackles the pressing issue of interoperability in healthcare. Kno2 excels in moving data efficiently across any medium, whether that’s traditional fax or modern FHIR standards. In this partnership, Redox provides robust infrastructure and expertise, transforming that raw data into actionable information. As Therasa Bell, President and Co-Founder of Kno2, puts it, the partnership will enhance data mobility and increase its relevance across the healthcare ecosystem.
Key Features of the Alliance
The collaboration offers numerous benefits aimed at improving connectivity and user experience:
- Unified Integration: A streamlined connection point that grants access to the full potential of the combined network.
- Scalable Architecture: A versatile connectivity solution that accommodates everything from small EHR systems to expansive health organizations, ensuring efficient data flow.
- Universal Data Translation: The capability to scale and normalize various data formats such as HL7v2 or FHIR, ensuring compatibility across all systems.
- Nationwide Connectivity: Through Kno2’s QHIN designation, integrated directly into the Redox platform, users gain access to federal health information networks.
Enhancing Healthcare Infrastructure
As CEO Trip Hofer of Redox explains, healthcare providers have long faced significant obstacles due to the fragmentation of data and inefficiencies in information systems. This partnership directly addresses these challenges by allowing organizations to connect once, rather than relying on numerous custom integrations. This approach not only simplifies the process but also enhances the overall interoperability of healthcare systems.
The increasing burden on healthcare organizations to comply with federal interoperability mandates is coupled with the necessity for diverse connectivity solutions. The collaboration permits organizations to benefit from both individual system integrations as well as access to large-scale networks, making it a game-changer in the healthcare landscape.
Looking Forward
Current clients of both Redox and Kno2 can begin utilizing this integrated solution with the assistance of their account representatives. For new customers, the combined offering will be available starting in early 2026. This forward-looking endeavor positions both companies at the forefront of transforming healthcare data exchange.
About Redox
Redox provides vital support for healthcare data interoperability. Catering to a wide range of stakeholders, including providers, payers, digital health vendors, EHR platforms, and life sciences organizations, Redox enables seamless data exchanges critical for improved care delivery. With a robust network featuring nearly 12,000 live integrations, organizations leverage the Redox Engine to streamline healthcare connectivity.
About Kno2
Kno2 is reshaping healthcare communication through its unmatched network, recognized as a Qualified Health Information Network (QHIN). This infrastructure facilitates secure and effortless exchanges of patient information amongst various stakeholders, processing vast amounts of transactions. Kno2's dedication is towards enhancing the future of healthcare communication.
Frequently Asked Questions
What is the purpose of the Redox and Kno2 alliance?
The alliance aims to enhance interoperability and facilitate real-time data exchange across various healthcare networks, making clinical data more usable.
How do Redox and Kno2 ensure data security?
Both companies employ innovative technologies and infrastructure designed to secure the sensitive nature of healthcare data during exchanges.
Who can benefit from the new integrated solution?
Both existing customers and new clients from different sectors within healthcare can leverage the capabilities of the integrated solution.
When will new offerings be available for customers?
New customers will have access to the combined offerings in early 2026.
What types of data formats will the solution support?
The partnership will support various formats, including HL7v2, FHIR, X12, and CDA, enhancing compatibility across systems.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.